An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors

By Kjeldsen Sverre   Mancia Giuseppe   Schmieder Roland   Mattheus Michaela   Unger Thomas  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 673-682

Informa Healthcare

Access to resources Recommend Favorite

Meta-analysis of three observational studies of amlodipine/valsartan in hypertensive patients with additional risk factors

By Eckert Siegfried   Freytag Siegfried B.   Müller Alfons   Klebs Sven H. G.  

Blood Pressure, Vol. 22, Iss. 1, 2013-09 ,pp. : 11-21

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of a Single-Pill Combination of Amlodipine/Valsartan in Asian Hypertensive Patients Not Adequately Controlled with Valsartan Monotherapy

By Huang Jun   Sun Ning-Ling   Hao Yu-Ming   Zhu Jun-Ren   Tu Yingmei   Curt Valentin   Zhang Ying  

Clinical and Experimental Hypertension, Vol. 33, Iss. 3, 2011-05 ,pp. : 179-186

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk factors are not treated to target in hypertensive patients in primary care

By Nieburg Ingegerd   Kahan Thomas  

Blood Pressure, Vol. 19, Iss. 3, 2010-06 ,pp. : 176-181

Informa Healthcare

Access to resources Recommend Favorite

Management of Cardiovascular Risk Factors in Patients with Metabolic Syndrome

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite